32 stories
All topics
A UK trial published in JAMA Psychiatry found that tocilizumab, an anti-inflammatory drug that blocks interleukin-6, eased depression, anxiety and fatigue — an early but promising step toward treatments matched to a person’s biology.
Japanese researchers engineered hybrid vitamin K compounds, one about three times better than natural vitamin K at coaxing neural stem cells into becoming neurons, hinting at future regenerative treatments for diseases like Alzheimer’s and Parkinson’s.
Texas A&M researchers developed a nasal spray of stem-cell–derived particles that, in animal studies, calmed chronic brain inflammation and restored memory after just two doses, with benefits lasting months.
Nature reports that AI-powered brain-computer interfaces are advancing from small clinical trials toward real-world use, with one patient decoding Mandarin at 300 characters per minute and another controlling devices by thought, alongside new ethics guidelines.
A UCL and Great Ormond Street Hospital study found that the gene therapy Luxturna can strengthen the visual pathways of young children with inherited blindness, with the greatest gains when treatment comes early in brain development.
Actor and filmmaker Jesse Eisenberg donated one of his kidneys to a person he had never met, a rare act known as a nondirected donation, at NYU Langone Health on December 30, 2025.
A study published April 15 in Nature Nanotechnology shows printed neurons made from molybdenum disulfide and graphene that can trigger lifelike spike, burst and continuous firing patterns in mouse brain slices — a step toward better neural prosthetics.
On a Southwest Airlines flight, crew announced that 2-year-old passenger Cruz had beaten stage 4 neuroblastoma, prompting the entire cabin to erupt in cheers and write messages of encouragement on napkins.
University of Michigan researchers developed "Prima," an AI that interprets brain MRI scans in seconds, identifying over 50 neurological conditions with up to 97.5% accuracy after training on 200,000+ studies.
Neuromorphic computers modeled after the human brain can now solve complex physics simulation equations, a feat once thought possible only with energy-hungry supercomputers, marking a new era of sustainable computing.
Engineers at South Korea's POSTECH built a spinal cord stimulator that stays stiff for safe insertion, then softens on contact with body fluids and uses liquid metal to keep stable signals as the body moves.
Researchers at the University of Michigan have created Prima, an AI vision-language model trained on over 200,000 MRI studies that can interpret brain scans in seconds, identify more than 50 neurological conditions, and flag emergencies for immediate specialist attention.
On 25 March 2026, the FDA approved Avlayah, the first biologic engineered to cross the blood-brain barrier to treat the neurological effects of Hunter syndrome — a rare childhood disorder — after a trial showed a 91% drop in a key disease marker in the brain.
The UK Biobank completed over one billion medical scans from 100,000 volunteers, creating the most comprehensive atlas of the human body ever assembled. Early analysis revealed that heart disease and brain disease often co-occur, suggesting cardiovascular health may protect against dementia.
A UC Davis-led clinical trial has safely performed the world's first spina bifida treatment combining fetal surgery with placenta-derived stem cells, with all six infants born with intact repair sites and reversed brain abnormalities.
An international consortium published over 21 papers mapping more than 3,000 cell types in the human brain, creating the most detailed atlas of the organ ever produced and opening new avenues for treating neurological diseases.
In new mirror experiments, cleaner wrasse spotted and removed fake parasites within an hour and even “tested” their reflections by dropping food, hints of a self-awareness once thought limited to a few brainy mammals.
Neuromorphic computers modeled after the human brain can now solve the complex equations behind physics simulations — something once thought possible only with energy-hungry supercomputers. This breakthrough could revolutionize scientific computing while dramatically reducing energy consumption.
UK doctors have reported a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent. The treatment targets the faulty gene responsible for the devastating neurodegenerative condition that affects around 30,000 people in the UK alone.
New research in 2025 declared 70 "the new 60," with studies showing that today's 70-year-olds are significantly healthier, more cognitively sharp, and more physically active than previous generations at the same age. The findings reflect decades of improvements in healthcare, nutrition, and lifestyle.
Every day at 3 PM, construction workers building Cleveland Clinic's new neurological institute stop to wave, make heart shapes, and hold up signs for Brinley, a 4-year-old waiting for a heart transplant across the way.
After nearly three decades of research, Brazilian scientists have developed polylaminin — a stabilized form of a natural human protein that acts as a scaffold for nerve regeneration. ANVISA has approved Phase 1 clinical trials, and early results, including a tetraplegic woman regaining arm movement within days, have been described as unprecedented.
Researchers at the University of Michigan have created Prima, an AI system that interprets brain MRI scans in seconds with up to 97.5% accuracy across 50+ neurological conditions, trained on 200,000+ studies and 5.6 million imaging sequences.
New research reveals that great apes can engage in imaginative play, pretending to pour and drink invisible tea, demonstrating cognitive abilities previously thought to be uniquely human.
A major longevity study published in 2025 found that today's 70-year-olds are physically and cognitively comparable to 60-year-olds from a generation ago, thanks to improvements in healthcare, nutrition, and lifestyle habits.
Being an involved grandparent is good for the brain — caring for grandchildren may serve as a buffer against cognitive decline and dementia in older adults.
The FDA cleared Flow Neuroscience's FL-100, a wearable headset delivering gentle electrical stimulation to treat major depression at home, the first device of its kind authorized in the US as a non-drug therapy.
Wandercraft's Atalante X, a hands-free self-balancing robotic exoskeleton, won its second FDA clearance, expanding use to people with spinal cord injuries from C4 to L5 and to those with multiple sclerosis.
Research shows that today's 70-year-olds are biologically and cognitively comparable to 60-year-olds from previous generations, thanks to advances in healthcare and lifestyle.
A UC Davis brain-computer interface translated a man's neural signals into synthesized speech with natural tone and melody in real time, letting him converse with family and even sing short tunes.
Researchers at Shanghai’s Fudan University implanted a brain-spine interface in four paralyzed patients, who regained leg movement within 24 hours and went on to walk again within weeks — a striking advance in restoring movement after spinal cord injury.
UC Berkeley and UCSF researchers reported in Nature Neuroscience a streaming brain-computer interface that turns a paralyzed woman's neural signals into audible speech in about a second, using AI and a recreation of her pre-injury voice.
